您当前所在的位置:首页 > 产品中心 > 产品详细信息
58-93-5 分子结构
点击图片或这里关闭

6-chloro-1,1-dioxo-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide

ChemBase编号:872
分子式:C7H8ClN3O4S2
平均质量:297.73912
单一同位素质量:296.96447543
SMILES和InChIs

SMILES:
Clc1c(S(=O)(=O)N)cc2S(=O)(=O)NCNc2c1
Canonical SMILES:
Clc1cc2NCNS(=O)(=O)c2cc1S(=O)(=O)N
InChI:
InChI=1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)
InChIKey:
JZUFKLXOESDKRF-UHFFFAOYSA-N

引用这个纪录

CBID:872 http://www.chembase.cn/molecule-872.html

Collapse All Expand All

名称和登记号

名称和登记号

名称 登记号
IUPAC标准名
6-chloro-1,1-dioxo-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide
6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
IUPAC传统名
hydrochlorothiazide
6-chloro-1,1-dioxo-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide
商标名
Acuretic
Aldoril
Apresazide
Aquarills
Aquarius
Bremil
Caplaril
Capozide
Chlorosulthiadil
Chlorzide
Cidrex
Dichlorosal
Dichlorotride
Dichlotiazid
Dichlotride
Diclotride
Dicyclotride
Direma
Disalunil
Diu-Melusin
Drenol
Esidrex
Esimil
Fluvin
Hidril
Hidrochlortiazid
Hidroronol
Hidrotiazida
Hydril
Hydro-Aquil
Hydro-Diuril
Hydrodiuretic
Hydropres
Hydrosaluric
Hydrothide
Hydrozide
Hypothiazid
Hypothiazide
Idrotiazide
Ivaugan
Jen-Diril
Lotensin Hct
Maschitt
Megadiuril
Moduretic
Nefrix
Neo-Codema
Neoflumen
Newtolide
Panurin
Ro-Hydrazide
Servithiazid
Thiaretic
Thiuretic
Thlaretic
Timolide
Urodiazin
Vetidrex
Ziac
别名
6-氯-3,4-二氢-2H-1,2,4-苯并噻二嗪-7-磺酰胺-1,1-二氧化物
6-氯-7-磺酰胺-3,4-二氢-1,2,4-苯并噻二嗪-1,1-二氧化物
氢氯噻嗪
6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~,2,4-benzothiadiazine-7-sulfonamide
HCTZ
HCZ
Dihydroxychlorothiazidum
Dihydrochlorurite
Dihydrochlorothiazidum
Dihydrochlorothiazid
Dihydrochlorothiazide
Dihydrochlorurit
Hydrochlorothiazid
Hydrochlorthiazide
Hydrochlorothiazide
Aquazide H
Carozide
Diaqua
Esidrix
Ezide
Hydrochlorothiazide
6-Chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
Esidrex
Vetidrex
Aquarius
Bremil
Cidrex
Dichlotride
Diurizid
Drenol
Hidrochlortiazid
Hydrex
Oretic
Pantemon
Thiuretic
6-Chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
CAS号
58-93-5
EC号
200-403-3
MDL号
MFCD00051765
Beilstein号
625101
默克索引号
144781
PubChem SID
24277806
160964335
24895542
PubChem CID
3639

理论计算性质

理论计算性质

JChem ALOGPS 2.1
Acid pKa 9.087113  质子受体
质子供体 LogD (pH = 5.5) -0.57571745 
LogD (pH = 7.4) -0.5834805  Log P -0.5756178 
摩尔折射率 63.1096 cm3 极化性 25.34669 Å3
极化表面积 118.36 Å2 可自由旋转的化学键
里宾斯基五规则 true 
Log P -0.16  LOG S -2.12 
溶解度 2.24e+00 g/l 

分子性质

分子性质

理化性质 安全信息 药理学性质 产品相关信息 生物活性(PubChem)
溶解度
0.7 mg/mL expand 查看数据来源
Methanol expand 查看数据来源
外观
crystalline expand 查看数据来源
White Solid expand 查看数据来源
熔点
266-272°C expand 查看数据来源
273-275°C expand 查看数据来源
273-277°C expand 查看数据来源
疏水性(logP)
-0.5 expand 查看数据来源
保存条件
-20°C expand 查看数据来源
-20°C Freezer expand 查看数据来源
Room Temperature (15-30°C) expand 查看数据来源
保存注意事项
Irritant expand 查看数据来源
RTECS编号
DK9100000 expand 查看数据来源
欧盟危险性物质标志
有害性(Harmful) 有害性(Harmful) (Xn) expand 查看数据来源
MSDS下载
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
德国WGK号
2 expand 查看数据来源
危险公开号
22 expand 查看数据来源
TSCA收录
expand 查看数据来源
GHS危险品标识
GHS07 expand 查看数据来源
GHS警示词
Warning expand 查看数据来源
GHS危险声明
H302 expand 查看数据来源
GHS警示性声明
P264-P270-P301+P312-P330-P501A expand 查看数据来源
个人保护装置
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter expand 查看数据来源
相关基因信息
human ... ALB(213), CA1(759), CA11(770), CA12(771), CA13(377677), CA14(23632), CA2(760), CA3(761), CA4(762), CA5A(763), CA6(765), CA7(766), CA8(767), CA9(768) expand 查看数据来源
human ... ALB(213), CA1(759), CA2(760), CA4(762) expand 查看数据来源
生物活性机理
Carbonic anhydrase inhibitor expand 查看数据来源
纯度
97% expand 查看数据来源
98% expand 查看数据来源
成盐信息
Free Base expand 查看数据来源
质检报告
下载链接 expand 查看数据来源
下载链接 expand 查看数据来源
适用性
meets USP testing specifications expand 查看数据来源
应用领域
Chloruretic expand 查看数据来源
Diuretic and antihypertensive agent expand 查看数据来源
Kaliuretic. expand 查看数据来源
Natriuretic expand 查看数据来源
Pharmacopeia Traceability
traceable to BP 186 expand 查看数据来源
traceable to PhEur H1200000 expand 查看数据来源
traceable to USP 1314009 expand 查看数据来源
Empirical Formula (Hill Notation)
C7H8ClN3O4S2 expand 查看数据来源

详细说明

详细说明

MP Biomedicals MP Biomedicals DrugBank DrugBank Selleck Chemicals Selleck Chemicals Sigma Aldrich Sigma Aldrich TRC TRC
MP Biomedicals -  02157403 external link
Crystalline
A carbonic anhydrase inhibitor
DrugBank -  DB00999 external link
Item Information
Drug Groups approved
Description A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It has been used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. [PubChem]
Indication For the treatment of high blood pressure and management of edema.
Pharmacology Thiazides such as hydrochlorothiazide promote water loss from the body (diuretics). They inhibit Na+/Cl- reabsorption from the distal convoluted tubules in the kidneys. Thiazides also cause loss of potassium and an increase in serum uric acid. Thiazides are often used to treat hypertension, but their hypotensive effects are not necessarily due to their diuretic activity. Thiazides have been shown to prevent hypertension-related morbidity and mortality although the mechanism is not fully understood. Thiazides cause vasodilation by activating calcium-activated potassium channels (large conductance) in vascular smooth muscles and inhibiting various carbonic anhydrases in vascular tissue.
Toxicity The most common signs and symptoms observed are those caused by electrolyte depletion (hypokalemia, hypochloremia, hyponatremia) and dehydration resulting from excessive diuresis. If digitalis has also been administered, hypokalemia may accentuate cardiac arrhythmias. The oral LD50 of hydrochlorothiazide is greater than 10 g/kg in the mouse and rat.
Affected Organisms
Humans and other mammals
Biotransformation Hydrochlorothiazide is not metabolized.
Absorption 50-60%
Half Life 5.6 and 14.8 hours
Protein Binding 67.9%
Elimination Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney. Hydrochlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk.
External Links
Wikipedia
RxList
Drugs.com
Selleck Chemicals -  S1708 external link
Research Area: Cardiovascular Disease
Biological Activity:
Ibuprofen Lysine (NeoProfen) is a non-selective COX inhibitor with an IC50 of 0.33 mM. It is known to have an antiplatelet effect, though Ibuprofen Lysine (NeoProfen) is relatively mild and short-lived when compared with that of aspirin or other better-known antiplatelet agents. [1] Ibuprofen, indomethacin, and meclofenamate were potent inhibitors of the microsomal cyclooxygenase prepared from feline lung with IC50 of 0.33 mM, 29 μM, and 4.7 μM, respectively. [2]
Sigma Aldrich -  H149 external link
Biochem/physiol Actions
碳酸酐酶抑制剂
Sigma Aldrich -  08213 external link
Biochem/physiol Actions
碳酸酐酶抑制剂
Sigma Aldrich -  H2910 external link
Biochem/physiol Actions
碳酸酐酶抑制剂
Sigma Aldrich -  H4759 external link
Biochem/physiol Actions
碳酸酐酶抑制剂
Toronto Research Chemicals -  H714560 external link
Hydrochlorothiazide is a carbonic anhydrase inhibitor as a diuretic.

参考文献

参考文献

供应商提供 Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • http://en.wikipedia.org/wiki/Hydrochlorothiazide
  • Piala, J.J., et al.: J. Pharmacol. Exp. Ther., 134, 273 (1961)
  • Deppeler, H.P., et al.: Anal. Profiles Drug Subs., 10, 405 (1961)
  • de Stevens, G. et al., Experientia, 1958, 14, 463
  • Swiss Pat., 1959, Ciba, 337 203; CA, 54, 21147i, (synth, pharmacol)
  • Close, W.J. et al., J.A.C.S., 1960, 82, 1132, (synth)
  • Werner, L.H. et al., J.A.C.S., 1960, 93, 1161, (synth, pharmacol)
  • Klosa, J. et al., J. Prakt. Chem., 1962, 16, 264, (synth)
  • Dupont, L. et al., Acta Cryst. B, 1972, 28, 2340, (cryst struct)
  • Beermann, B. et al., Clin. Pharmacol. Ther. (St. Louis), 1976, 19, 531, (metab)
  • Deppeler, H.P., Anal. Profiles Drug Subst., 1981, 10, 405, (rev)
  • Negwer, M., Organic-Chemical Drugs and their Synonyms, 6th edn., Akademie-Verlag, 1987, 681, (synonyms)
  • IARC Monog., 1990, 50, 293, (rev, tox)
  • Danielsen-Runge, W., Dtsch. Apoth. -Ztg., 1992, 132, 1950, (rev)
  • Kountourellis, J.E. et al., J. Chem. Eng. Data, 1992, 37, 187, (cryst struct)
  • Diuretics IV: Proc. Int. Conf. Diuretics, 4th, 1992, (eds. Puschett, J.B. et al), Excerpta Medica, Amsterdam, 1993, (pharmacol)
  • Martindale, The Extra Pharmacopoeia, 30th edn., Pharmaceutical Press, 1993, 818
  • Gottdiener, J.S. et al., Circulation, 1997, 95, 2007, (use)
  • Lewis, R.J., Sax's Dangerous Properties of Industrial Materials, 8th edn., Van Nostrand Reinhold, 1992, CFY000
正在搜索,请耐心等待...(如果遇到网页错误或者长时间没有结果,请刷新页面[F5])

专利

专利

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

互联网资源

互联网资源

百度图标百度 google iconGoogle